Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study by admin | May 31, 2022 | Clinical trials ... Read More | Share it now!
